ストックスクリーナーアプリを入手
20.07
1.45%
-0.295
前日終値:
$20.37
開ける：
$20.2
24時間の取引高:
4.13M
Relative Volume:
0.50
時価総額：
$10.32B
収益：
$10.89B
当期純損益:
$-241.00M
株価収益率:
-75.58
EPS:
-0.2656
ネットキャッシュフロー:
$340.00M
1週間 パフォーマンス:
-4.72%
1か月 パフォーマンス:
+5.38%
6か月 パフォーマンス:
-29.24%
1年 パフォーマンス:
-35.14%
1日の値動き範囲:
$20.05
$20.41
1週間の範囲:
$19.36
$21.03
52週間の値動き範囲:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.07 | 10.47B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
533.08 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.74 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.35 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.64 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.47 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $23, Maintains Neutral Rating - marketscreener.com
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety - The Globe and Mail
Manning & Napier Advisors LLC Sells 51,029 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Baxter CEO outlines plan to slash debt, boost pipeline in 2026 - Crain's Chicago Business
Baxter International Inc. Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in HospitalSettings - marketscreener.com
BaxterDynamo series is now available for order in the U.S. and is expected to be available during the first half of 2026 - marketscreener.com
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Rutland Herald
Baxter Introduces the Dynamo Series, A New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Baxter
Does Baxter International (BAX) Now Look Fairly Priced After Multi‑Year Share Price Slide - Yahoo Finance
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Why Baxter (BAX) Stock Is Trading Lower Today - The Globe and Mail
Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside - DirectorsTalk Interviews
Stock Traders Buy Large Volume of Baxter International Put Options (NYSE:BAX) - MarketBeat
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges - Bioscience Association Manitoba
The Truth About Baxter International Inc.: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
SG Americas Securities LLC Grows Stock Holdings in Baxter International Inc. $BAX - MarketBeat
Barclays Cuts Baxter International (NYSE:BAX) Price Target to $30.00 - MarketBeat
Barclays Adjusts Price Target on Baxter International to $30 From $36, Maintains Overweight Rating - marketscreener.com
Baxter International Inc.: How a 90-Year Medtech Veteran Is Rebuilding Its Flagship Portfolio - AD HOC NEWS
A Look At Baxter International (BAX) Valuation After New MUSC Health Connected Care Partnership - Sahm
Why Baxter International Inc. stock is in analyst buy zoneJuly 2025 Reactions & Community Trade Idea Sharing Platform - ulpravda.ru
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Price Swings & Safe Capital Investment Plans - ulpravda.ru
Breakout Move: Can Baxter International Inc. stock attract ESG capital inflowsJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - ulpravda.ru
Will Baxter International Inc. stock outperform Nasdaq index2025 Major Catalysts & AI Optimized Trading Strategy Guides - ulpravda.ru
How strong is Baxter International Inc. stock revenue growthJuly 2025 WrapUp & AI Driven Price Predictions - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology - Investing.com Australia
Is Baxter International Inc. stock vulnerable to regulatory risksExit Point & Fast Moving Market Watchlists - ulpravda.ru
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address - PharmiWeb.com
Baxter partnership - The Medical University of South Carolina
Signal Recap: Can Baxter International Inc. stock weather global recession2025 Price Targets & High Win Rate Trade Alerts - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology By Investing.com - Investing.com South Africa
Will Baxter International Inc. stock see insider accumulationTrade Entry Summary & High Return Trade Guides - ulpravda.ru
Fund Update: 4,404,874 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Baxter to Present at J.P. Morgan 2026 Healthcare Conference - MarketScreener
New fraud claims filed in federal lawsuits against IV pump company - KMOV
Baxter International (NYSE:BAX) Given New $23.00 Price Target at Evercore ISI - MarketBeat
How to watch Baxter’s CEO at the 2026 J.P. Morgan healthcare conference - Stock Titan
The Truth About Baxter International (NYSEreplacing with BCRX): Is This Biotech Underdog About To - AD HOC NEWS
Evercore ISI Adjusts Price Target on Baxter International to $23 From $24 - marketscreener.com
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $24 - 富途牛牛
Artisan Mid Cap Value Fund’s Views on Baxter International (BAX) - Insider Monkey
How Investors Are Reacting To Baxter (BAX) Debt Tender Offers And Smart Infusion EMR Data - simplywall.st
Assessing Baxter International (BAX) Valuation After Recent Share Price Momentum And Margin Concerns - Yahoo Finance
How Investors May Respond To Baxter (BAX) Retiring Near‑Term Debt And Advancing Connected Infusion Therapy - Yahoo Finance
The Truth About Baxter International Inc.: Is This ‘Boring’ Stock a Secret Power Play? - AD HOC NEWS
Baxter International (BAX) and Vaneck Gold Miners ETF (GDX) top the Bull Strangle watch list for next week - Barchart.com
Baxter International Inc Stock Price Live, Charts & News - The Economic Times
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What do analysts think about Baxter International Inc. (BAX)? - MSN
What Do Analysts Think About Baxter International Inc. (BAX)? - Insider Monkey
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.82%
大文字化:
|
ボリューム (24 時間):